International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.





Walter J. Hamlin Professor and Chair
Northwestern University Feinberg Medical School
United States
IPC Board Member
Dr. Amy Paller is the Walter J. Hamlin Professor and Chair of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center at Northwestern University’s Feinberg School of Medicine. She received her undergraduate and graduate degrees from Brown University and her medical degree from Stanford University. Dr. Paller completed residency training in Pediatrics and Dermatology at Northwestern University and her postdoctoral research fellowship at the University of North Carolina. She is President of the International Society of Pediatric Dermatology (ISPD) and President-Elect of the American Dermatological Association (ADA). She has served as President of the Society for Investigative Dermatology (SID), the Society for Pediatric Dermatology (SPD), the International Eczema Council (IEC), the Pediatric Dermatology Research Alliance (PeDRA), and the Women’s Dermatological Society (WDS). She has also been on the Board of many national and international organizations, including the American Academy of Dermatology (AAD) and the American Board of Dermatology (ABD). Dr. Paller has served on the editorial boards of leading journals and is currently a Section Editor of the Journal of Investigative Dermatology (JID). She has written several leading textbooks, including the leading textbook for pediatric dermatology, Hurwitz Clinical Pediatric Dermatology. An author of more than 650 original publications, Dr. Paller is an NIH-funded investigator conducting laboratory-based and clinical investigations related to psoriasis. Dr. Paller has led international epidemiological studies related to psoriasis, has developed new tools to measure patient-related outcomes in pediatric psoriasis, and is focused on psoriasis-related research related to obesity, cutaneous innervation, and new nanotechnology-based approaches to treatment. She has been the lead investigator on landmark trials in pediatric skin disease, including the trial of the first TNF inhibitor and first IL-17 inhibitor for children with psoriasis. She has served on the Medical Advisory Board (now Emeritus) and received the Excellence in Leadership Award from the National Psoriasis Foundation (NPF). Dr. Paller has been an active IPC Councilor since 2010.
Last Updated:

Areas of Interest

Bench research – studying: a) nano construct gene-regulatory treatment of psoriasis; b) neuro-immunology-keratinocyte cross-talk and psoriasis; and c) mechanism of obesity-induced impact on severity and responses of psoriasis Clinical research – epidemiologic studies; clinical trials; patient-reported outcomes research (developed new tools to assess pediatric itch (PROMIS Itch Questionnaire – Childhood; Stigma tool). Patient reported outcomes tool development and measurements, pediatric dermatology.

IPC Committees / Groups

Board Member, Pediatrics Project

Languages Spoken


Involvement with Other Organization(s)

Participates in the National Psoriasis Foundation’s (NPF) activities; previous NPF medical board member.